Z. Kopp

发表

Impact of overactive bladder symptoms on employment, social interactions and emotional well‐being in six European countries

P. Abrams, L. Cardozo, D. Irwin, 2006, BJU international.

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

K. Coyne, P. Abrams, C. Kelleher, 2006, European urology.

Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction

P. Abrams, B. Agatep, D. Irwin, 2011, BJU international.

The economic impact of overactive bladder syndrome in six Western countries

C. Kelleher, P. Reeves, D. Irwin, 2009, BJU international.

The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

Andrea Tubaro, C. Thompson, K. Coyne, 2009, BJU international.

Impact of overactive bladder on work productivity in the United States: results from EpiLUTS.

T. Wagner, K. Coyne, D. Irwin, 2009, The American journal of managed care.

Initial assessment of urinary and faecal incontinence in adult male and female patients

K. Coyne, C. Kelleher, A. Emmanuel, 2009 .

Excess Morbidity and Cost of Failure to Achieve Targets for Blood Pressure Control in Europe

L. Hansson, Z. Kopp, A. Lloyd, 2002, Blood pressure.

Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion

V. Nitti, Z. Kopp, K. Moore, 2010, Neurourology and urodynamics.

Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS

K. Coyne, S. Kaplan, C. Chapple, 2009, BJU international.

Translating overactive bladder questionnaires in 14 languages.

C. Acquadro, K. Coyne, Seung-June Oh, 2006, Urology.

Standardized Telephonic Case Management in a Hispanic Heart Failure Population

B. Riegel, B. Carlson, T. Romero, 2002 .

Who is Responsible for Discharge Education of Patients? A Multi-Institutional Survey of Internal Medicine Residents

L. Horwitz, M. Schwartz, P. Williams, 2021, Journal of General Internal Medicine.

ME Cares: a statewide system engaging providers in disease management.

Z. Kopp, R. Wexler, Claudette Bean, 2004, Disease management : DM.

Amlodipine treatment in patients undergoing PTCA in the UK: a cost-effectiveness analysis

J. Doyle, E. Thaulow, Z. Kopp, 2002 .

PRO Questionnaires to Screen and Measure Satisfaction, Expectations and Goal Achievement

L. Brubaker, Z. Kopp, C. Evans, 2010 .

Psychometric equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish.

K. Coyne, M. Margolis, Z. Kopp, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The impact of lower urinary tract symptoms on male sexual health: EpiLUTS

K. Coyne, A. Wein, A. Tubaro, 2009, BJU international.

LUTS patient reported outcomes tool: Linguistic validation in 10 European languages

K. Coyne, B. Brandt, Z. Kopp, 2013, Neurourology and urodynamics.

Symptom bother and health care-seeking behavior among individuals with overactive bladder.

P. Abrams, D. Irwin, I. Milsom, 2008, European urology.

Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.

P. Abrams, W. Artibani, S. Herschorn, 2009, European urology.

The current and future burden and cost of overactive bladder in five European countries.

C. Kelleher, P. Reeves, D. Irwin, 2006, European urology.

Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men.

K. Coyne, P. Abrams, C. Kelleher, 2008, The journal of sexual medicine.

The placebo effect in overactive bladder syndrome

C. Chapple, Z. Kopp, A. Mangera, 2011, Nature Reviews Urology.

Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo

K. Coyne, C. Kelleher, M. Brodsky, 2009, Health and quality of life outcomes.

The impact of overactive bladder on mental health, work productivity and health‐related quality of life in the UK and Sweden: results from EpiLUTS

K. Coyne, C. Chapple, I. Milsom, 2011, BJU international.

The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well‐being in men and women: results from the EPIC study

K. Coyne, C. Kelleher, D. Irwin, 2008, BJU international.

Determining the importance of change in the overactive bladder questionnaire.

L. Matza, C. Thompson, K. Coyne, 2006, The Journal of urology.

Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.

K. Coyne, L. Brubaker, C. Chapple, 2006, Urology.

The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder.

L. Matza, K. Coyne, P. Abrams, 2006, European urology.

A Narrative Review of Patient-reported Outcomes in Overactive Bladder: What is the Way of the Future?

C. Kelleher, Morgan Mako, C. Chapple, 2016, European urology.

National community prevalence of overactive bladder in the United States stratified by sex and age.

C. Thompson, K. Coyne, I. Milsom, 2011, Urology.

Antimuscarinic Treatments in Overactive Bladder

C. Chapple, Z. Kopp, D. Muston, 2010 .

Lower urinary tract symptoms in women—A common but neglected problem

K. Coyne, D. Irwin, Z. Kopp, 2008, Journal of the American Academy of Nurse Practitioners.

Sustained improvement in patient‐reported outcomes during long‐term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open‐label extension studies

R. Dmochowski, C. Kelleher, Z. Kopp, 2012, BJU international.

Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.

K. Coyne, S. Kaplan, I. Milsom, 2012, Urology.

Development of an overactive bladder assessment tool (BAT): A potential improvement to the standard bladder diary

Y. Homma, C. Kelleher, C. Chapple, 2018, Neurourology and urodynamics.

Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States.

K. Coyne, M. Kvasz, C. Chapple, 2012, European urology.

The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health‐related quality of life, anxiety and depression: EpiLUTS

C. Thompson, K. Coyne, A. Wein, 2009, BJU international.

The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder

K. Coyne, B. Cash, H. Gelhorn, 2011, BJU international.

Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study.

K. Coyne, S. Kaplan, M. Margolis, 2012, Urology.

The impact of OAB on sexual health in men and women: results from EpiLUTS.

C. Thompson, K. Coyne, S. Kaplan, 2011, The journal of sexual medicine.

It's just the worry about not being able to control it! A qualitative study of living with overactive bladder.

C. Kelleher, C. Chapple, Z. Kopp, 2008, British journal of health psychology.

Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure.

B. Riegel, A. Unger, B. Carlson, 2002, Archives of internal medicine.

Systematic review of the relationship between bladder and bowel function: implications for patient management

S. Kaplan, R. Dmochowski, Z. Kopp, 2013, International journal of clinical practice.

Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review.

M. Chancellor, D. Irwin, I. Milsom, 2010, European urology.

The psychometric validation of a 1-week recall period for the OAB-q

C. Thompson, K. Coyne, H. Gelhorn, 2011, International Urogynecology Journal.

Understanding the elements of overactive bladder: questions raised by the EPIC study

P. Abrams, D. Irwin, I. Milsom, 2008, BJU international.

Impact of fesoterodine on quality of life: pooled data from two randomized trials

C. Kelleher, A. Tubaro, Z. Kopp, 2008, BJU international.

Do urological symptoms cluster among women? Results from the Boston Area Community Health Survey

C. Roehrborn, R. Rosen, C. Link, 2008, BJU international.

A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and Canada.

S. Arikian, J. Doyle, E. Thaulow, 2002, International journal of cardiology.

THE COST‐EFFECTIVENESS OF DOXAZOSIN FOR THE TREATMENT OF HYPERTENSION IN TYPE II DIABETIC PATIENTS IN THE UK AND ITALY

S. Arikian, J. Doyle, Z. Kopp, 2001, International journal of clinical practice.

Discharge Communication: A Multi-Institutional Survey of Internal Medicine Residents' Education and Practices.

L. Horwitz, M. Schwartz, Z. Kopp, 2020, Academic medicine : journal of the Association of American Medical Colleges.

A Missed Opportunity: Advance Care Planning Documentation in Patients with COVID-19 (W205C)

Fangdi Sun, E. Cummings, Z. Kopp, 2021, Journal of Pain and Symptom Management.

Rationale for the study methods and design of the epidemiology of lower urinary tract symptoms (EpiLUTS) study

K. Coyne, D. Irwin, I. Milsom, 2009, BJU international.

Examining lower urinary tract symptom constellations using cluster analysis

L. Matza, C. Thompson, K. Coyne, 2008, BJU international.

Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms

C. Roehrborn, S. Kaplan, R. Rosen, 2009, BJU international.

The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS

K. Coyne, A. Wein, A. Tubaro, 2009, BJU international.

Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB Outcomes.

Y. Homma, C. Kelleher, C. Chapple, 2021, European urology focus.

Assessing patients’ descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research

K. Coyne, T. Symonds, C. Chapple, 2010, International journal of clinical practice.

Looking to the Future: Medical Students' Views on Health Care Reform and Professional Responsibility.

C. Davey, Z. Kopp, J. M. Rook, 2019, Academic medicine : journal of the Association of American Medical Colleges.

UIJ - Lower urinary tract symptoms (LUTS), symptom overlap, psychosocial impact, and cardiovascular disease in men: Findings from the boston area community health survey (BACH)

C. Roehrborn, S. Kaplan, R. Rosen, 2008 .

DO UROLOGIC SYMPTOMS CLUSTER AMONG WOMEN? RESULTS FROM THE BOSTON AREA COMMUNITY HEALTH SURVEY

C. Roehrborn, S. Kaplan, R. Rosen, 2008 .

PREVALENCE OF OVERACTIVE BLADDER SYNDROME: EUROPEAN RESULTS FROM THE EPIC STUDY

P. Abrams, C. Kelleher, S. Hunskaar, 2006 .

Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS)

C. Thompson, K. Coyne, A. Barsdorf, 2012, Neurourology and urodynamics.

O616 The impact of OAB on female sexual health: The EpiLUTS study

K. Coyne, I. Milsom, Z. Kopp, 2009 .

Reliability, Validity, and Interpretation of the Dependence Scale in Mild to Moderately Severe Alzheimer’s Disease

Y. Stern, K. Wyrwich, M. Stolar, 2013, American journal of Alzheimer's disease and other dementias.

Development and validation of the overactive bladder satisfaction (OAB‐S) questionnaire

P. Abrams, L. Brubaker, E. Piault, 2008, Neurourology and urodynamics.

Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire

C. Kelleher, J. Trocio, L. Brubaker, 2011, International Urogynecology Journal.

71 TYPES OF URINARY INCONTINENCE AND BODY MASS INDEX: RESULTS FROM EPILUTS

K. Coyne, I. Milsom, Z. Kopp, 2012 .

Validation study of the Self‐Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms

L. Brubaker, C. Kelleher, J. Trocio, 2013, International journal of clinical practice.

TOLTERODINE EXTENDED RELEASE (ER) FOR OVERACTIVE BLADDER (OAB): CORRELATIONS AMONG IMPROVEMENTS IN OBJECTIVE SYMPTOMS, PATIENT PERCEPTION OF BLADDER CONDITION (PPBC), AND HEALTH-RELATED QUALITY OF LIFE (HRQL)

K. Coyne, M. Brodsky, Z. Kopp, 2006 .

PUK22 PATIENT SATISFACTION: INTERNATIONAL DEVELOPMENT, TRANSLATABILITY ASSESSMENT AND LINGUISTIC VALIDATION OF THE OAB-S, AN OVERACTIVE BLADDER TREATMENT SATISFACTION QUESTIONNAIRE

P. Abrams, L. Brubaker, E. Piault, 2005 .

Nocturia: risk factors and associated comorbidities; findings from the EpiLUTS study

K. Coyne, C. Chapple, I. Milsom, 2015, International journal of clinical practice.

ORIGINAL RESEARCH—ERECTILE DYSFUNCTION Overactive Bladder Is Associated with Erectile Dysfunction and Reduced Sexual Quality of Life in Men

K. Coyne, P. Abrams, C. Kelleher, 2008 .

Cluster analysis and lower urinary tract symptoms in men: findings from the Boston Area Community Health Survey

C. Roehrborn, R. Rosen, C. Link, 2008, BJU international.

Cluster analysis and lower urinary tract symptoms in men: findings from the Boston Area Community Health Survey

C. Roehrborn, R. Rosen, C. Link, 2008, BJU international.

Do urological symptoms cluster among women? Results from the Boston Area Community Health Survey

C. Roehrborn, R. Rosen, C. Link, 2008, BJU international.

Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.

K. Coyne, S. Kaplan, I. Milsom, 2012, Urology.

Assessing patients’ descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research

K. Coyne, T. Symonds, C. Chapple, 2010, International journal of clinical practice.

Assessing outcomes in OAB: What is the way of the future?

C. Kelleher, Morgan Mako, C. Chapple, 2015 .